Table 4.

Concern for receiving care based on monthly income among the patients

Variables	Income [n (%)]		OR (95% CI)	P
	≤ 250 US$	> 250 US$
Concern for replacing internationally branded medicines with Iranian branded medicines because of price increase in the future as sanctions continue	482 (73.5)	174 (26.5)	1.20 (0.87-1.66))	0.250
Concern for replacing expensive drugs with cheaper alternatives due to financial problems in the future as sanctions continue	497 (76.9)	149 (23.1)	2.04 (1.50-2.77)*	< 0.001*
Unwillingness to continue treatment due to increased economic burden of the disease	333 (81.2)	77 (18.8)	2.02 (1.49-2.73)*	< 0.001*
Unwillingness to continue treatment due to increased mental burden	325 (77.6)	94 (22.4)	1.45 (1.08-1.94)*	0.010*
Eliminating or diminishing social activities	449 (75.6)	145 (24.4)	1.30 (0.98-1.74)	0.060
Eliminating or diminishing physical activities	493 (74.4)	167 (25.3)	1.20 (0.89-1.61)	0.220
Reduced nutrition quality	545 (79.8)	138 (20.2)	2.68 (1.99-3.60)*	< 0.001*

OR: Odds ratio; CI: Confidence interval

^*Significant results compared to other odds ratios and 95% confidence intervals